Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Hepatitis C

Free Subscription Articles published in Dig Dis Sci Retrieve available abstracts of 26 articles: HTML format

Single Articles

July 2024
1. MAKOVICH Z, Radosavljevic I, Chapyala S, Handley G, et al
   Rationale for Hepatitis C Virus Treatment During Hematopoietic Stem Cell Transplant in the Era of Novel Direct-Acting Antivirals.
   Dig Dis Sci. 2024 Jul 11. doi: 10.1007/s10620-024-08541.
   PubMed     Abstract available
   
   
   
2. CHANG CW, Hsu WF, Tseng KC, Chen CY, et al
   Benefits of Hepatitis C Viral Eradication: A Real-World Nationwide Cohort Study in Taiwan.
   Dig Dis Sci. 2024 Jul 4. doi: 10.1007/s10620-024-08512.
   PubMed     Abstract available
   
   
   April 2024
3. PEARLMAN BL
   Direct-Acting Antiviral Therapy for Patients with Chronic Hepatitis C Infection and Decompensated Cirrhosis.
   Dig Dis Sci. 2024 Apr 5. doi: 10.1007/s10620-024-08393.
   PubMed     Abstract available
   
   
   April 2023
4. RUSTAM LB, Vander Weg M, Chrischilles E, Tanaka T, et al
   Sociodemographic and Clinical Factors Associated with Nonattendance at the Hepatology Clinic.
   Dig Dis Sci. 2023 Apr 27. doi: 10.1007/s10620-023-07951.
   PubMed     Abstract available
   
   
   
5. MAJEED NA, Alawad AS, Liem KS, Takyar V, et al
   Low Rate of Hepatitis B Reactivation Among Patients with Chronic Hepatitis C During Direct Acting Antiviral Therapy.
   Dig Dis Sci. 2023 Apr 6. doi: 10.1007/s10620-023-07916.
   PubMed     Abstract available
   
   
   February 2023
6. BONKOVSKY HL, Rudnick SP, Ma CD, Overbey JR, et al
   Ledipasvir/Sofosbuvir Is Effective as Sole Treatment of Porphyria Cutanea Tarda with Chronic Hepatitis C.
   Dig Dis Sci. 2023 Feb 22. doi: 10.1007/s10620-023-07859.
   PubMed     Abstract available
   
   
   December 2022
7. XU J, Wang Y, Feng H, Liu F, et al
   HBV/HCV Infection Was Not Significantly Independently Associated with COVID-19 Severity: A Meta-Analysis of Confounding Variables-Adjusted Data.
   Dig Dis Sci. 2022 Dec 23:1-3. doi: 10.1007/s10620-022-07799.
   PubMed    
   
   
   
8. JINDAL A, Agarwal S, Sharma S, Kumar M, et al
   Assessment of the Performance of Non-invasive Criteria for the Evaluation of Clinically Significant Portal Hypertension in Patients with Compensated Advanced Chronic Liver Disease.
   Dig Dis Sci. 2022 Dec 23. doi: 10.1007/s10620-022-07778.
   PubMed     Abstract available
   
   
   
9. TAHATA Y, Sakamori R, Yamada R, Kodama T, et al
   Improved Liver Function After Sustained Virologic Response Enhanced Prognosis in Hepatitis C with Compensated Advanced Liver Fibrosis.
   Dig Dis Sci. 2022 Dec 16. doi: 10.1007/s10620-022-07629.
   PubMed     Abstract available
   
   
   October 2022
10. LIU YC, Cheng YT, Chen YC, Hsieh YC, et al
    Correction: Comparing Predictability of Noninvasive Tools for Hepatocellular Carcinoma in Treated Chronic Hepatitis C Patients.
    Dig Dis Sci. 2022 Oct 17. pii: 10.1007/s10620-022-07683.
    PubMed    
    
    
    September 2022
11. HONMA Y, Shibata M, Morino K, Koya Y, et al
    Impact of Interferon-Free Direct-Acting Antivirals on the Incidence of Extrahepatic Malignancies in Patients with Chronic Hepatitis C.
    Dig Dis Sci. 2022 Sep 14. pii: 10.1007/s10620-022-07686.
    PubMed     Abstract available
    
    
    July 2022
12. LIU YC, Cheng YT, Chen YC, Hsieh YC, et al
    Comparing Predictability of Non-invasive Tools for Hepatocellular Carcinoma in Treated Chronic Hepatitis C Patients Characters: 102 (< 120).
    Dig Dis Sci. 2022 Jul 27. pii: 10.1007/s10620-022-07621.
    PubMed     Abstract available
    
    
    May 2022
13. CLARK PJ, Valery PC, Strasser SI, Weltman M, et al
    Liver Disease and Poor Adherence Limit Hepatitis C Cure: A Real-World Australian Treatment Cohort.
    Dig Dis Sci. 2022 May 13. pii: 10.1007/s10620-022-07483.
    PubMed     Abstract available
    
    
    
14. RAO A, Rule JA, Cerro-Chiang G, Stravitz RT, et al
    Role of Hepatitis C Infection in Acute Liver Injury/Acute Liver Failure in North America.
    Dig Dis Sci. 2022 May 11. pii: 10.1007/s10620-022-07524.
    PubMed     Abstract available
    
    
    March 2022
15. ANIEMEKA C, Pillai AA
    HCC Mortality Trends-In with ALD (and NAFLD) and Out with HCV.
    Dig Dis Sci. 2022 Mar 14. pii: 10.1007/s10620-022-07434.
    PubMed    
    
    
    
16. RAMANI A, Tapper EB, Griffin C, Shankar N, et al
    Hepatocellular Carcinoma-Related Mortality in the USA, 1999-2018.
    Dig Dis Sci. 2022 Mar 14. pii: 10.1007/s10620-022-07433.
    PubMed     Abstract available
    
    
    May 2021
17. PINYOPORNPANISH K, Al-Yaman W, Dasarathy S, Romero-Marrero C, et al
    Hepatocellular Carcinoma in Patients Without Cirrhosis: The Fibrosis Stage Distribution, Characteristics and Survival.
    Dig Dis Sci. 2021 May 23. pii: 10.1007/s10620-021-07048.
    PubMed     Abstract available
    
    
    March 2021
18. LE E, Chee G, Kwan M, Cheung R, et al
    Treating the Hardest to Treat: Reframing the Hospital Admission as an Opportunity to Initiate Hepatitis C Treatment.
    Dig Dis Sci. 2021 Mar 26. pii: 10.1007/s10620-021-06941.
    PubMed     Abstract available
    
    
    February 2021
19. KANG N, Chung JW, Jang ES, Jeong SH, et al
    Computed Tomography-Measured Liver Volume Predicts the Risk of Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients.
    Dig Dis Sci. 2021 Feb 25. pii: 10.1007/s10620-020-06762.
    PubMed     Abstract available
    
    
    
20. EVON DM, Kim HP, Edwards A, Carda-Auten J, et al
    "If I Get Cured, My Whole Quality of Life Will Change": Patients' Anticipated and Actualized Benefits Following Cure from Chronic Hepatitis C.
    Dig Dis Sci. 2021 Feb 2. pii: 10.1007/s10620-021-06829.
    PubMed     Abstract available
    
    
    January 2021
21. HONG SW, Choi WM, Hwang HW, Kim DS, et al
    Chronic Viral Hepatitis Is Associated with Colorectal Neoplasia: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2021 Jan 12. pii: 10.1007/s10620-020-06745.
    PubMed     Abstract available
    
    
    August 2020
22. DENG LX, Mehta N
    Does Hepatocellular Carcinoma Surveillance Increase Survival in At-Risk Populations? Patient Selection, Biomarkers, and Barriers.
    Dig Dis Sci. 2020 Aug 29. pii: 10.1007/s10620-020-06550.
    PubMed     Abstract available
    
    
    
23. FONG TL, Lee BT, Chang M, Nasanbayar K, et al
    High Prevalence of Chronic Viral Hepatitis and Liver Fibrosis Among Mongols in Southern California.
    Dig Dis Sci. 2020 Aug 8. pii: 10.1007/s10620-020-06499.
    PubMed     Abstract available
    
    
    January 2020
24. ENOMOTO M, Kawada N
    The Moral of Hepatic Fibrosis: Don't Always Believe Noninvasive Fibrosis Measurements.
    Dig Dis Sci. 2020 Jan 1. pii: 10.1007/s10620-019-06035.
    PubMed    
    
    
    November 2019
25. LIANG KH, Zhang P, Lin CL, Wang SC, et al
    Morphomic Signatures Derived from Computed Tomography Predict Hepatocellular Carcinoma Occurrence in Cirrhotic Patients.
    Dig Dis Sci. 2019 Nov 2. pii: 10.1007/s10620-019-05915.
    PubMed     Abstract available
    
    
    October 2019
26. ZOU B, Yeo YH, Jeong D, Park H, et al
    A Nationwide Study of Inpatient Admissions, Mortality, and Costs for Patients with Cirrhosis from 2005 to 2015 in the USA.
    Dig Dis Sci. 2019 Oct 9. pii: 10.1007/s10620-019-05869.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge.